ClinicalTrials.Veeva

Menu
A

AC Camargo Cancer Center | International Research Center (CIPE)

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Vincristine
Doxorubicin
Cyclophosphamide
Prednisone
TAR-200
Bendamustine
Pembrolizumab
Cisplatin
Bemarituzumab
Elotuzumab

Parent organization

This site is a part of AC Camargo Cancer Center

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 10 total trials
Locations recently updated

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder (SunRISe-2)

The purpose of study is to compare bladder intact-event free survival (BI-EFS) in participants receiving TAR-200 in combination with intravenous (IV)...

Active, not recruiting
Urinary Bladder Neoplasms
Drug: Cisplatin
Radiation: Hypo-fractioned radiation therapy

This study is researching an experimental drug called linvoseltamab, also called REGN5458.Linvoseltamab has previously been studied by itself (withou...

Enrolling
Relapsed Refractory Multiple Myeloma (RRMM)
Drug: Pomalidomide
Drug: Elotuzumab

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously u...

Enrolling
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Vincristine

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously u...

Enrolling
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Rituximab

The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6)...

Active, not recruiting
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Other: Placebo
Drug: Nivolumab

Trial sponsors

Regeneron Pharmaceuticals logo
A
Amgen logo
Janssen (J&J Innovative Medicine) logo
National Cancer Institute (NCI) logo
Takeda logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems